Kyntra Bio (KYNB) Asset Utilization Ratio (2015 - 2026)
Kyntra Bio (KYNB) posted Asset Utilization Ratio of 0.06 for Q1 2026, up 29.31% sequentially from 0.05 in Q4 2025, and up 92.65% YoY from 0.03 in Q1 2025.
Kyntra Bio (KYNB) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
Kyntra Bio has reported Asset Utilization Ratio for 12 years, with the latest figure at 0.06 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 92.65% year-over-year to 0.06 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.06 (up 92.65% YoY) and the FY2025 annual result came in at 0.04, down 58.48% from the prior year.
- Asset Utilization Ratio advanced to 0.06 in Q1 2026 per KYNB's latest filing, from 0.05 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.3 in Q2 2022 and troughed at 0.25 in Q3 2024.
- A 5-year average of 0.05 and a median of 0.05 in 2025 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio plunged 292.42% in 2024, then soared 177.87% in 2025.
- Over 5 years, Asset Utilization Ratio stood at 0.1 in 2022, then sank by 138.03% to 0.04 in 2023, then soared by 161.51% to 0.02 in 2024, then soared by 105.19% to 0.05 in 2025, then grew by 29.31% to 0.06 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.06, 0.05, and 0.05 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.65 Bn | 130.80 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.94 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.84 Bn | 59.66 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.38 Bn | 52.25 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 27.72 Bn | 9.33 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.13 |
| 10 | Kyntra Bio | 30.56 Mn | 30.56 Mn | 1.47 Mn | 0.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.07 |
| Mar 31, 2026 | 0.06 |
| Dec 31, 2025 | 0.05 |
| Sep 30, 2025 | 0.05 |
| Jun 30, 2025 | 0.04 |
| Mar 31, 2025 | 0.03 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | -0.25 |
| Jun 30, 2024 | -0.09 |
| Mar 31, 2024 | -0.04 |
| Dec 31, 2023 | -0.04 |
| Sep 30, 2023 | 0.13 |
| Jun 30, 2023 | 0.08 |
| Mar 31, 2023 | 0.10 |
| Dec 31, 2022 | 0.10 |
| Sep 30, 2022 | 0.11 |
| Jun 30, 2022 | 0.30 |
| Mar 31, 2022 | 0.27 |
| Dec 31, 2021 | 0.25 |
| Sep 30, 2021 | 0.30 |